46. Malignant rheumatoid arthritis Clinical trials / Disease details

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02264301 (ClinicalTrials.gov)	August 2014	3/10/2014	Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis	The Effect of Qingkailing Injection on Corticosteroids Withdrawal Rate in Patients With Active Rheumatoid Arthritis	Rheumatoid Arthritis	Drug: Puerarin injection 400 mg;Drug: Qingkailing injection 40 ml	Chengdu PLA General Hospital	NULL	Enrolling by invitation	18 Years	75 Years	All	150	N/A	China
2	NCT02219191 (ClinicalTrials.gov)	August 2014	16/7/2014	Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases	The Effect of Puerarin Tablets in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases	Rheumatoid Arthritis	Drug: puerarin tablet 50 mg;Drug: Atorvastatin tablet 20 mg	Chengdu PLA General Hospital	NULL	Active, not recruiting	18 Years	75 Years	All	150	N/A	China
3	NCT02254655 (ClinicalTrials.gov)	November 2013	18/11/2013	The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis	The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis, a Controlled and Randomized Trial	Rheumatoid Arthritis	Drug: Puerarin injection 400 mg;Drug: Control	Chengdu PLA General Hospital	NULL	Completed	18 Years	75 Years	All	119	Phase 2	China